TetraLogic Pharmaceuticals Corporation
TLOG · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $188 | $0 | $0 | $0 |
| Gross Profit | -$188 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $27,402 | $20,287 | $9,523 | $12,096 |
| G&A Expenses | $11,099 | $10,927 | $8,467 | $4,076 |
| SG&A Expenses | $11,099 | $10,927 | $8,467 | $4,076 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38,500 | $31,214 | $17,991 | $16,172 |
| Operating Income | -$44,991 | -$33,786 | -$17,991 | -$16,172 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$11,224 | -$4,745 | -$1,960 | -$28 |
| Pre-Tax Income | -$49,724 | -$35,959 | -$19,950 | -$16,199 |
| Tax Expense | $6,384 | $3,359 | $2,767 | $73 |
| Net Income | -$56,108 | -$39,318 | -$22,718 | -$16,273 |
| % Margin | – | – | – | – |
| EPS | -2.37 | -1.76 | -9.9 | -16.78 |
| % Growth | -34.7% | 82.2% | 41% | – |
| EPS Diluted | -2.36 | -1.76 | -9.9 | -16.78 |
| Weighted Avg Shares Out | 23,692 | 22,290 | 2,296 | 970 |
| Weighted Avg Shares Out Dil | 23,730 | 22,352 | 2,296 | 970 |
| Supplemental Information | – | – | – | – |
| Interest Income | $100 | $113 | $1 | $3 |
| Interest Expense | $6,384 | $3,359 | $2,767 | $73 |
| Depreciation & Amortization | $6,778 | $2,811 | $100 | $157 |
| EBITDA | -$43,152 | -$32,474 | -$17,083 | -$15,972 |
| % Margin | – | – | – | – |